Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In this article, Ill unpack what CMS originally planned to do, what these GLP-1s are currently approved for, and how the reversal impacts patients, physicians, and the broader health system
Nov 7 2025;doi:10.1056/NEJMoa2513032
Estimates suggest that around 5% of people in the United States have MASH, and around a third have an earlier stage, metabolic dysfunction-associated steatotic liver disease (MASLD)
& Raia, V
Bonus - Semaglutide has the added benefit of aiding weight loss and supporting better glycaemic control in T2 Diabetes (as well as all of the other benefits that this wonder drug is capable of)
US$ 25.47
US$ 21.54
US$ 27.98
